Fusion Pharmaceuticals (FUSN) Insider Trading & Ownership → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free FUSN Stock Alerts $21.42 +0.02 (+0.09%) (As of 04/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Fusion Pharmaceuticals (NASDAQ:FUSN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.75%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$161,335.71Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$517,191.81 Get FUSN Insider Trade Alerts Want to know when executives and insiders are buying or selling Fusion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FUSN Insider Buying and Selling by Quarter Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy Fusion Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/11/2022Steven GannonDirectorBuy44,400$2.03$90,132.00 4/27/2022John ValliantCEOSell4,511$6.03$27,201.33 4/25/2022John ValliantCEOSell2,036$6.03$12,277.08 4/20/2022John ValliantCEOSell367$6.02$2,209.34 4/13/2022John ValliantCEOSell11,994$6.41$76,881.54 4/11/2022John ValliantCEOSell2,600$7.37$19,162.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/8/2022John ValliantCEOSell826$7.52$6,211.52 4/6/2022John ValliantCEOSell100$7.58$758.00 3/30/2022John ValliantCEOSell300$7.52$2,256.00 3/28/2022John ValliantCEOSell9,600$7.55$72,480.00 3/25/2022John ValliantCEOSell500$7.42$3,710.00 3/23/2022John ValliantCEOSell100$7.50$750.00 3/21/2022John ValliantCEOSell1,500$7.47$11,205.00 3/17/2022John ValliantCEOSell900$7.51$6,759.00 3/7/2022John ValliantCEOSell3,100$6.99$21,669.00 3/4/2022John ValliantCEOSell8,400$7.32$61,488.00 2/28/2022John ValliantCEOSell3,100$7.40$22,940.00 2/24/2022John ValliantCEOSell2,500$7.41$18,525.00 2/22/2022John ValliantCEOSell4,100$7.85$32,185.00 2/17/2022John ValliantCEOSell1,700$7.98$13,566.00 2/15/2022John ValliantCEOSell12,600$8.33$104,958.00 8/23/2021Steven GannonDirectorBuy2,829$7.99$22,603.71 8/16/2021Steven GannonDirectorBuy6,000$8.10$48,600.00 (Data available from 1/1/2013 forward) FUSN Insider Trading Activity - Frequently Asked Questions Who is on Fusion Pharmaceuticals's Insider Roster? The list of insiders at Fusion Pharmaceuticals includes John Valliant, and Steven Gannon. Learn more on insiders at FUSN. What percentage of Fusion Pharmaceuticals stock is owned by insiders? 7.75% of Fusion Pharmaceuticals stock is owned by insiders. Learn more on FUSN's insider holdings. Which Fusion Pharmaceuticals insiders have been buying company stock? The following insider purchased FUSN shares in the last 24 months: Steven Gannon ($90,132.00). How much insider buying is happening at Fusion Pharmaceuticals? Insiders have purchased a total of 44,400 FUSN shares in the last 24 months for a total of $90,132.00 bought. Which Fusion Pharmaceuticals insiders have been selling company stock? The following insider sold FUSN shares in the last 24 months: John Valliant ($27,201.33). How much insider selling is happening at Fusion Pharmaceuticals? Insiders have sold a total of 4,511 Fusion Pharmaceuticals shares in the last 24 months for a total of $27,201.33 sold. More Insider Trading Tools from MarketBeat Related Companies: Recursion Pharmaceuticals Insider Trades Ambrx Biopharma Insider Trades Sana Biotechnology Insider Trades Neumora Therapeutics Insider Trades Twist Bioscience Insider Trades Inhibrx Insider Trades Ginkgo Bioworks Insider Trades Kymera Therapeutics Insider Trades Beam Therapeutics Insider Trades ADMA Biologics Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:FUSN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
